nicotine has been researched along with Movement Disorders in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buhlman, LM; Call, GB; Chambers, RP; Meyer, D; Pearman, K; Smith, J; Techau, JA | 1 |
| Bordia, T; Perez, XA; Quik, M; Zhang, D | 2 |
| Bordia, T; McIntosh, JM; Quik, M | 1 |
| LISUNKIN, IuI | 1 |
| ROUSSINOV, K | 1 |
| Bédard, MA; Beuter, A; Blanchet, P; Chouinard, S; Lemay, S; Masson, H; Soland, V | 1 |
| Bonta, IL; De Vos, CJ; Grijsen, H; Hillen, FC; Noach, EL; Sim, AW | 1 |
| Diamond, EL; Kessler, II | 1 |
2 review(s) available for nicotine and Movement Disorders
| Article | Year |
|---|---|
Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.
Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Drug Design; Dyskinesia, Drug-Induced; Humans; Movement Disorders; Nicotine; Nicotinic Agonists; Receptors, Nicotinic | 2014 |
Nicotine and Nicotinic Receptor Drugs: Potential for Parkinson's Disease and Drug-Induced Movement Disorders.
Topics: Antiparkinson Agents; Humans; Movement Disorders; Nicotine; Parkinson Disease | 2015 |
1 trial(s) available for nicotine and Movement Disorders
| Article | Year |
|---|---|
Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease.
Topics: Administration, Cutaneous; Aged; Biomechanical Phenomena; Cognition Disorders; Female; Humans; Male; Middle Aged; Movement Disorders; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Parkinson Disease; Psychomotor Performance; Reaction Time; Verbal Learning | 2004 |
6 other study(ies) available for nicotine and Movement Disorders
| Article | Year |
|---|---|
Nicotine increases lifespan and rescues olfactory and motor deficits in a Drosophila model of Parkinson's disease.
Topics: Alleles; Animals; Brain; Disease Progression; Drosophila melanogaster; Female; Flight, Animal; Immunohistochemistry; Life Expectancy; Male; Motor Activity; Movement Disorders; Mutation; Nicotine; Nicotinic Agonists; Olfaction Disorders; Parkinson Disease; Sex Characteristics; Smell; Tyrosine 3-Monooxygenase; Ubiquitin-Protein Ligases | 2013 |
Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats.
Topics: Animals; Antipsychotic Agents; Catalepsy; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dyskinesia, Drug-Induced; Haloperidol; Male; Movement Disorders; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic | 2012 |
["Sensitizing" and "desensitizing" effect of atropine, bete, and amizil on the anticonvulsant activity of pentafen and tropacin].
Topics: Anticonvulsants; Atropine; Benactyzine; Movement Disorders; Nervous System Physiological Phenomena; Nicotine; Parasympatholytics; Scopolamine; Tropanes | 1962 |
ON CERTAIN CORRELATIONS OF THE ANTICONVULSIVE DRUGS PHENYLCARBAMIDE, META-TOLYLCARBAMIDE AND PHENURONE WITH CHOLINERGIC AND ADRENERGIC MECHANISMS IN THE CENTRAL NERVOUS SYSTEM.
Topics: Adrenergic Agents; Animals; Anticonvulsants; Benzeneacetamides; Cholinergic Agents; Mice; Movement Disorders; Nicotine; Pharmacology; Phenylurea Compounds; Research; Toxicology; Urea | 1964 |
1-Hydroxy-3-amino-pyrrolidone-2(HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases.
Topics: Acoustic Stimulation; Amines; Amphetamine; Animals; Basal Ganglia Diseases; Behavior, Animal; Brain Chemistry; Cats; Corpus Striatum; Dogs; Dopamine; Electroencephalography; Exploratory Behavior; Hepatectomy; Male; Mice; Motor Activity; Movement Disorders; Nicotine; Pyrrolidinones; Rabbits; Rats; Reflex; Strychnine; Tremor; Tremorine | 1971 |
Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: a survey and explanatory hypothesis.
Topics: Adolescent; Adult; Aged; Amines; Child; Facial Expression; Female; Humans; Male; Middle Aged; Movement Disorders; Nicotine; Parkinson Disease; Parkinson Disease, Secondary; Retrospective Studies; Smoking; Speech Disorders; Time Factors | 1971 |